How is HPV DNA collected?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How HPV DNA is Collected

HPV DNA is collected primarily through cervical specimens obtained by a clinician using a brush or spatula to sample cells from the cervix, which are then placed in liquid-based cytology medium or transport medium for laboratory testing. 1

Standard Collection Methods

Clinician-Collected Cervical Specimens

The gold standard for HPV DNA collection involves:

  • Cervical sampling during pelvic examination using instruments designed to sample the cervical transformation zone (e.g., cytobrushes, spatulas)
  • Cells are collected by scraping or brushing the cervix
  • Specimens are placed in liquid-based cytology medium or viral transport medium
  • Both liquid-based and conventional cytology collection methods are acceptable 1

Important timing considerations:

  • Conventional cytology (dry slide) should ideally be scheduled 10-20 days after the first day of menses
  • Liquid-based cytology can be performed at any time during the menstrual cycle 1

Specimen Processing

HPV cannot be cultured—detection requires identification of HPV genetic information (DNA in the majority of assay formats) 2. The anatomic region sampled and the method of specimen collection significantly impact detection 2.

FDA-cleared tests detect viral DNA or messenger RNA and are only cleared for use with cervical specimens, not oral or anal specimens 1. HPV testing can be performed either as a separate test or using material from the liquid-based cytology specimen 1.

Alternative Collection Methods

Self-Collection (Not FDA-Cleared in U.S.)

While self-collection for HPV testing is not cleared by FDA or recommended by U.S. medical organizations 1, research shows:

  • Self-collected vaginal specimens using swab-based devices show high concordance with clinician-collected samples 3, 4
  • Samples for HPV testing have the potential to be collected by the patient and mailed to health programs for analysis 1
  • Self-collected vaginal swabs demonstrate superior performance compared to tampon-based methods 3

Other Specimen Types (Research/Investigational)

First-void urine:

  • Emerging as a credible specimen for HPV-based cervical cancer screening 5
  • Self-collected vaginal HPV DNA testing is more sensitive than unpreserved-urine samples 6
  • High concordance rates (90%) for HPV positivity between paired urine and cervical samples have been demonstrated 7

Blood (cell-free DNA):

  • Detection of circulating tumor tissue modified viral (TTMV)-HPV DNA shows promise for oropharyngeal cancer surveillance 8
  • Not used for primary cervical cancer screening

Oral specimens:

  • Oral rinses or swabs are used in research settings for HPV-associated oropharyngeal cancer 5
  • HPV testing should not be performed on oral specimens for cervical cancer screening 1

Critical Caveats

What NOT to do:

  • Do not use HPV tests on oral or anal specimens for cervical cancer screening 1
  • Do not test for low-risk (nononcogenic) HPV types like 6 and 11 1
  • Do not use acetic acid application as a screening test—acetowhitening is not specific for HPV 9
  • Do not postpone cytology testing due to mucopurulent discharge; the test can be performed after removal of discharge 1

Sequence of collection:

  • The sequence of cytology testing in relation to collection of other endocervical specimens does not influence results 1
  • Vaginal specimens are preferred for chlamydia and gonorrhea screening, but endocervical specimens for STI testing can be collected first during pelvic examination 1

References

Guideline

sexually transmitted infections treatment guidelines, 2021.

MMWR Recommendations and Reports, 2021

Research

Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.